Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination.
Zaloum SA, Wood CH, Tank P, Upcott M, Vickaryous N, Anderson V, Baker D, Chance R, Evangelou N, George K, Giovannoni G, Harding KE, Hibbert A, Ingram G, Jolles S, Kang AS, Loveless S, Moat SJ, Richards A, Robertson NP, Rios F, Schmierer K, Willis M, Dobson R, Tallantyre EC. Zaloum SA, et al. Among authors: vickaryous n. Mult Scler. 2023 Jul;29(8):979-989. doi: 10.1177/13524585231185247. Mult Scler. 2023. PMID: 37431627 Free PMC article.
Vitamin D genetic risk scores in multiple sclerosis.
Kuri A, Vickaryous N, Awad A, Jacobs BM, Dobson R. Kuri A, et al. Among authors: vickaryous n. J Neurol. 2023 Feb;270(2):1030-1035. doi: 10.1007/s00415-022-11466-4. Epub 2022 Nov 5. J Neurol. 2023. PMID: 36334133 Free PMC article.
A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosis.
Dobson R, Holden D, Vickaryous N, Bestwick J, George K, Sayali T, Bianchi L, Wafa M, Gold J, Giovannoni G. Dobson R, et al. Among authors: vickaryous n. Mult Scler. 2024 Jan;30(1):63-70. doi: 10.1177/13524585231215268. Epub 2023 Dec 22. Mult Scler. 2024. PMID: 38131621 Free PMC article. Clinical Trial.
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis.
Tallantyre EC, Scurr MJ, Vickaryous N, Richards A, Anderson V, Baker D, Chance R, Evangelou N, George K, Giovannoni G, Harding KE, Hibbert A, Ingram G, Jolles S, Jones M, Kang AS, Loveless S, Moat SJ, Robertson NP, Rios F, Schmierer K, Willis M, Godkin A, Dobson R. Tallantyre EC, et al. Among authors: vickaryous n. Mult Scler Relat Disord. 2022 Aug;64:103937. doi: 10.1016/j.msard.2022.103937. Epub 2022 Jun 4. Mult Scler Relat Disord. 2022. PMID: 35700625 Free PMC article.
COVID-19 Vaccine Response in People with Multiple Sclerosis.
Tallantyre EC, Vickaryous N, Anderson V, Asardag AN, Baker D, Bestwick J, Bramhall K, Chance R, Evangelou N, George K, Giovannoni G, Godkin A, Grant L, Harding KE, Hibbert A, Ingram G, Jones M, Kang AS, Loveless S, Moat SJ, Robertson NP, Schmierer K, Scurr MJ, Shah SN, Simmons J, Upcott M, Willis M, Jolles S, Dobson R. Tallantyre EC, et al. Among authors: vickaryous n. Ann Neurol. 2022 Jan;91(1):89-100. doi: 10.1002/ana.26251. Epub 2021 Nov 17. Ann Neurol. 2022. PMID: 34687063 Free PMC article.
19 results